Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its ...

The investment will make the Indianapolis facility the hub for manufacturing of Roche’s continuous glucose monitoring system.

Roche announced today that it plans to invest up to $550 million to expand its continuous glucose monitoring (CGM) site in ...

Officials with Roche Diagnostics announced on Monday that it will invest $550 million in its Indianapolis site by 2030.

The investment, which is expected to be complete by 2030, will boost U.S. production of Roche’s continuous glucose monitoring ...

Genentech unit plans to invest more than $700M in a new drug manufacturing facility in Holly Springs, North Carolina. The ...

A digital health application (DiGA) has been shown to relieve the distress that patients can experience when managing diabetes ... alongside products like its Accu-Chek blood glucose testing ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public alert on the circulation of ...

INDIANAPOLIS — Roche has announced plans to invest up to $550 million in its Diagnostics facility in Indianapolis by 2030.

INDIANAPOLIS — Biotech giant Roche has announced a $550 million investment in Indianapolis that will expand its diagnostics ...

Roche announces $550 million investment to make Indianapolis a hub for diabetes monitoring solution manufacturing. Roche expects to create hundreds of highly-skilled manufacturing jobs and thousands ...